|News & Media|
|Eddy Anglade, M.D.|
Founder, Chief Medical Officer
Dr. Anglade is the Chief Medical Officer of
Lux Biosciences, Inc.
Prior to joining Enzon, Dr. Anglade served as Medical Director and Team Leader at Roche Laboratories, Inc. in the areas of virology and transplantation marketing. While at Roche, Dr. Anglade led a diverse team in the development and implementation of post-marketing studies with a budget exceeding $15 million for its transplantation (CellCept® and Zenapax®) and virology (Cytovene®) franchises.
Dr. Anglade received his B.A. in Biology
from Columbia University and M.D. from Yale University. After completion
of an internship in Internal Medicine at Boston City Hospital, Dr.
© 2012 Lux Biosciences, Inc. All rights reserved. Web Terms